Related Experiment Video

Updated: May 31, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C (chronic)

Abdul Mohsen1, Suzanne Norris

  • 1Department of Gastroenterology, Chelsea and Westminster Hospital, London, UK.

BMJ Clinical Evidence
|July 2, 2011
PubMed

Insights

Chronic hepatitis C affects 3% of the global population. This review evaluates interferon and ribavirin treatments for hepatitis C virus (HCV) infection in various patient groups.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Clinical Evidence

Background:

  • Chronic hepatitis C affects a significant portion of the global population, estimated at 3%.
  • Hepatitis C virus (HCV) infection frequently leads to chronic disease, with 60-85% of infected individuals developing long-term complications.

Purpose of the Study:

  • To systematically review the effectiveness and safety of interventions for chronic hepatitis C.
  • To address specific clinical questions regarding treatment-naïve patients, those unresponsive to interferon, those relapsing after interferon, and patients with co-existing HIV infection.

Main Methods:

  • A systematic literature search was conducted across major databases (Medline, Embase, Cochrane Library) up to April 2008.
  • Inclusion criteria encompassed systematic reviews, randomized controlled trials (RCTs), and observational studies.
  • Harms alerts from regulatory agencies (FDA, MHRA) were also incorporated.

Main Results:

  • 35 systematic reviews, RCTs, or observational studies met the inclusion criteria.
  • A GRADE evaluation was performed to assess the quality of evidence for various interventions.

Conclusions:

  • The review presents data on the effectiveness and safety of interferon monotherapy.
  • Information on interferon alfa plus ribavirin, peginterferon monotherapy, and peginterferon plus ribavirin is also provided.
Abstract

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...